shopping cart

Confirmation purchase	Item Code	Item Description	Price
	CER8616	Long-term costs and outcomes in psoriatic arthritis patients not responding to conventional therapy treated with tumour necrosis factor inhibitors: the extension of the Psoriatic Arthritis Cost Evaluation (PACE) study	20.00 €
			Subtotal 20.00 €